[Bronchodilator substances. Part II: experimental study of a new antiasthmatic drug, S 1688, without beta-stimulant properties].
D000284:Administration, Oral; D000707:Anaphylaxis / Q000188:drug therapy; D000818:Animals; D001249:Asthma / Q000517:prevention & control*; D001549:Benzamides / Q000627:therapeutic use*; D001986:Bronchial Spasm / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use* / Q000633:toxicity; D004285:Dogs; D006168:Guinea Pigs; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007545:Isoproterenol / Q000627:therapeutic use; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D010879:Piperazines / Q000627:therapeutic use / Q000633:toxicity; D011342:Procainamide / Q000031:analogs & derivatives*; D011433:Propranolol / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use / Q000633:toxicity; D011817:Rabbits; D051381:Rats
D001549:Benzamides; D001993:Bronchodilator Agents; D010879:Piperazines; D011725:Pyridines; D011433:Propranolol; D011342:Procainamide; D007545:Isoproterenol